ProtoKinetix Inc (PKTX)

[scoobey-do]

I have heard many times in the past that the market anticipates six months into the future. The Primary Completion of the Islet Transplantation Study using PKX-001 is anticipated as September 2018, same as estimated in March 2017. To me, this means the study is going as planned, with Study Completion anticipated as January 2019. If we don't hear negative results of the study by September 2018, the market should anticipate favorable results and adjust the PPS accordingly. IMO